SELECTA BIOSCIENCES INC·4

Sep 26, 6:00 PM ET

TRABER PETER G 4

4 · SELECTA BIOSCIENCES INC · Filed Sep 26, 2023

Insider Transaction Report

Form 4
Period: 2023-09-25
TRABER PETER G
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-09-25$1.06/sh705$747451,826 total
Footnotes (2)
  • [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
  • [F2]Includes 6,410 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2022 and February 28, 2023.

Documents

1 file
  • 4
    wk-form4_1695765617.xmlPrimary

    FORM 4